Volume 91 Issue 27 | p. 21 | Concentrates
Issue Date: July 8, 2013

King Pharmaceuticals Fined For Air Pollution

Department: Government & Policy
Keywords: King Pharmaceuticals, Pfizer, UPM Pharmaceuticals, air pollution, emissions, Clean Air Act

King Pharmaceuticals has agreed to pay a $2.2 million fine and take steps to resolve allegations by federal prosecutors that emissions from the drug manufacturer’s Bristol, Tenn., plant violated the Clean Air Act. According to the complaint, King failed to adequately control emissions of methylene chloride and other hazardous air pollutants, violated the terms of its construction permit, and did not obtain the proper operating permit, as required under the . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society